Bismuth Subsalicylate Oral Suspension from Japan
A liquid mixture containing bismuth subsalicylate as the active ingredient, combined with inorganic suspending agents, used for treating upset stomach, diarrhea, and heartburn. It falls under HTS 3824.99.31.00 as a mixture of two or more inorganic compounds of bismuth not elsewhere specified, specifically formulated for pharmaceutical use.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• Verify exact bismuth compound composition to confirm classification under 3824.99.31.00; pharmaceutical mixtures may require FDA registration and drug import alerts
• Include certificates of analysis showing inorganic bismuth content and ensure labeling complies with US pharmacopeia standards to avoid CBP reclassification